Immune system culprit in severe COVID cases found
Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.
Apr 28, 2022
0
55
Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.
Apr 28, 2022
0
55
A research team led by experts at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center reports favorable five-year survival rates from the first multidose clinical trial of the ...
Jul 25, 2019
2
1276
The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun".
Jul 5, 2024
0
67
A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating ...
Jun 27, 2023
1
474
Immunologists in Australia have eavesdropped on a stowaway population of B cells that hide in the lungs, their telltale biomarkers indicating they're armed to fight influenza—and their presence yet another sign that the ...
Researchers worldwide have been surprised to see that individuals can be infected with the SARS-CoV-2 virus—the virus that produces COVID-19—without showing symptoms. Since these individuals expose others to infection ...
Oct 28, 2020
0
9
A new study explains why lung cancer spreads faster in patients with certain genetic changes, and suggests that taking vitamin E, long thought of as preventive, may cause the same spread.
Jun 27, 2019
0
4
Patrick Vallance, chief scientific adviser to the UK government, recently said that many groups are working on blood tests for COVID-19, adding: "That would tell us who has had it and now has antibodies, therefore won't catch ...
Mar 31, 2020
0
10
The vast majority of deadly lung cancer cases (85 percent) are termed non-small-cell lung carcinomas (NSCLCs), which often contain a mutated gene called LKB1. Salk Institute researchers have now discovered precisely why inactive ...
Jul 27, 2019
0
663
Lung cancer is the second most common cancer in the U.S. and the No. 1 cause of cancer related death. Despite considerable progress in treatment options, most lung cancer patients have extremely poor outcomes with an average ...
Feb 11, 2022
0
1096